Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study
Background: Recent changes in the acid-related disease market, particularly the emergence of potassium-competitive acid blockers (P-CABs), require an updated analysis of trends in gastric acid suppressant utilization. Objectives: As the use of P-CAB expands globally, a cross-sectional study is neede...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/17562848251356406 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839628534961668096 |
|---|---|
| author | Min Jeong Je Jeong Min Go Shin Yeong Kim Min-Gul Kim Hankil Lee Ha-Lim Jeon Jae Hyun Kim |
| author_facet | Min Jeong Je Jeong Min Go Shin Yeong Kim Min-Gul Kim Hankil Lee Ha-Lim Jeon Jae Hyun Kim |
| author_sort | Min Jeong Je |
| collection | DOAJ |
| description | Background: Recent changes in the acid-related disease market, particularly the emergence of potassium-competitive acid blockers (P-CABs), require an updated analysis of trends in gastric acid suppressant utilization. Objectives: As the use of P-CAB expands globally, a cross-sectional study is needed to assess its association with potential adverse events from a pharmacovigilance perspective. Design: Cross-sectional study. Methods: We analyzed gastric acid suppressant use at prescription and patient levels using the Health Insurance Review and Assessment National Patient Sample database (2014–2020). Prescription-level analysis included the annual prescriptions for histamine-2 receptor antagonists (H2RAs), proton pump inhibitors (PPIs), and P-CABs, and proportion of visits by acid-related indications. Patient-level analysis examined annual trends in drug use and clinical characteristics. Logistic regression was used to estimate prevalence odds ratios (ORs) for potential adverse events among drug users and non-users according to the drug class. Results: In 2020, H2RAs were primarily prescribed for gastritis and duodenitis (64.5%), whereas PPIs (55.4%) and P-CABs (58.6%) were primarily used to treat gastroesophageal reflux disease. H2RA prescriptions declined in 2019, whereas the use of P-CAB increased following the approval of tegoprazan in 2018. Patients aged 40–64 years and female users were predominant across all classes of gastric acid suppressants. P-CAB use was significantly associated with osteoporosis (OR = 1.17; 95% confidence interval (CI): 1.13–1.20), pneumonia (OR = 1.65, 95% CI: 1.55–1.75), and acute kidney injury (OR = 1.39, 95% CI: 1.20–1.61). Conclusion: P-CABs have reshaped the prescription landscape of gastric acid suppressants. Further longitudinal cohort studies are required to evaluate long-term safety in routine clinical practice. |
| format | Article |
| id | doaj-art-0b8bc36e16d1408a992c99f3a0a8d77b |
| institution | Matheson Library |
| issn | 1756-2848 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Gastroenterology |
| spelling | doaj-art-0b8bc36e16d1408a992c99f3a0a8d77b2025-07-15T16:03:36ZengSAGE PublishingTherapeutic Advances in Gastroenterology1756-28482025-07-011810.1177/17562848251356406Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional studyMin Jeong JeJeong Min GoShin Yeong KimMin-Gul KimHankil LeeHa-Lim JeonJae Hyun KimBackground: Recent changes in the acid-related disease market, particularly the emergence of potassium-competitive acid blockers (P-CABs), require an updated analysis of trends in gastric acid suppressant utilization. Objectives: As the use of P-CAB expands globally, a cross-sectional study is needed to assess its association with potential adverse events from a pharmacovigilance perspective. Design: Cross-sectional study. Methods: We analyzed gastric acid suppressant use at prescription and patient levels using the Health Insurance Review and Assessment National Patient Sample database (2014–2020). Prescription-level analysis included the annual prescriptions for histamine-2 receptor antagonists (H2RAs), proton pump inhibitors (PPIs), and P-CABs, and proportion of visits by acid-related indications. Patient-level analysis examined annual trends in drug use and clinical characteristics. Logistic regression was used to estimate prevalence odds ratios (ORs) for potential adverse events among drug users and non-users according to the drug class. Results: In 2020, H2RAs were primarily prescribed for gastritis and duodenitis (64.5%), whereas PPIs (55.4%) and P-CABs (58.6%) were primarily used to treat gastroesophageal reflux disease. H2RA prescriptions declined in 2019, whereas the use of P-CAB increased following the approval of tegoprazan in 2018. Patients aged 40–64 years and female users were predominant across all classes of gastric acid suppressants. P-CAB use was significantly associated with osteoporosis (OR = 1.17; 95% confidence interval (CI): 1.13–1.20), pneumonia (OR = 1.65, 95% CI: 1.55–1.75), and acute kidney injury (OR = 1.39, 95% CI: 1.20–1.61). Conclusion: P-CABs have reshaped the prescription landscape of gastric acid suppressants. Further longitudinal cohort studies are required to evaluate long-term safety in routine clinical practice.https://doi.org/10.1177/17562848251356406 |
| spellingShingle | Min Jeong Je Jeong Min Go Shin Yeong Kim Min-Gul Kim Hankil Lee Ha-Lim Jeon Jae Hyun Kim Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study Therapeutic Advances in Gastroenterology |
| title | Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study |
| title_full | Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study |
| title_fullStr | Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study |
| title_full_unstemmed | Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study |
| title_short | Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study |
| title_sort | prescription trends of gastric acid suppressants and association with potential adverse events in korea a real world cross sectional study |
| url | https://doi.org/10.1177/17562848251356406 |
| work_keys_str_mv | AT minjeongje prescriptiontrendsofgastricacidsuppressantsandassociationwithpotentialadverseeventsinkoreaarealworldcrosssectionalstudy AT jeongmingo prescriptiontrendsofgastricacidsuppressantsandassociationwithpotentialadverseeventsinkoreaarealworldcrosssectionalstudy AT shinyeongkim prescriptiontrendsofgastricacidsuppressantsandassociationwithpotentialadverseeventsinkoreaarealworldcrosssectionalstudy AT mingulkim prescriptiontrendsofgastricacidsuppressantsandassociationwithpotentialadverseeventsinkoreaarealworldcrosssectionalstudy AT hankillee prescriptiontrendsofgastricacidsuppressantsandassociationwithpotentialadverseeventsinkoreaarealworldcrosssectionalstudy AT halimjeon prescriptiontrendsofgastricacidsuppressantsandassociationwithpotentialadverseeventsinkoreaarealworldcrosssectionalstudy AT jaehyunkim prescriptiontrendsofgastricacidsuppressantsandassociationwithpotentialadverseeventsinkoreaarealworldcrosssectionalstudy |